Goldenberg SL - Search Results

1

[Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma].

Bruchovsky N, Goldenberg SL, Rennie PS, Gleave M. Bruchovsky N, et al. Among authors: goldenberg sl. Urologe A. 1995 Sep;34(5):389-92. Urologe A. 1995. PMID: 7483155 Review. German.

2

Use of cyproterone acetate in prostate cancer.

Goldenberg SL, Bruchovsky N. Goldenberg SL, et al. Urol Clin North Am. 1991 Feb;18(1):111-22. Urol Clin North Am. 1991. PMID: 1825143 Review.

3

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.

Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, To M, Lawson D. Bruchovsky N, et al. Among authors: goldenberg sl. Cancer Res. 1990 Apr 15;50(8):2275-82. Cancer Res. 1990. PMID: 2317815

4

Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.

Bruchovsky N, Rennie PS, Batzold FH, Goldenberg SL, Fletcher T, McLoughlin MG. Bruchovsky N, et al. Among authors: goldenberg sl. J Clin Endocrinol Metab. 1988 Oct;67(4):806-16. doi: 10.1210/jcem-67-4-806. J Clin Endocrinol Metab. 1988. PMID: 2458378

5

Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.

Rennie PS, Bruchovsky N, Goldenberg SL, Lawson D, Fletcher T, Foekens JA. Rennie PS, et al. Among authors: goldenberg sl. J Urol. 1988 Jun;139(6):1337-42. doi: 10.1016/s0022-5347(17)42914-4. J Urol. 1988. PMID: 2967378

6

The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.

Goldenberg SL, Bruchovsky N, Rennie PS, Coppin CM. Goldenberg SL, et al. J Urol. 1988 Dec;140(6):1460-5. doi: 10.1016/s0022-5347(17)42073-8. J Urol. 1988. PMID: 2973529

7

Relationship of androgen receptors to the growth and regression of the prostate.

Rennie PS, Bruchovsky N, Goldenberg SL. Rennie PS, et al. Among authors: goldenberg sl. Am J Clin Oncol. 1988;11 Suppl 2:S13-7. doi: 10.1097/00000421-198801102-00004. Am J Clin Oncol. 1988. PMID: 3071950 Review.

8

The endocrinology and treatment of prostate tumor progression.

Bruchovsky N, Brown EM, Coppin CM, Goldenberg SL, Le Riche JC, Murray NC, Rennie PS. Bruchovsky N, et al. Among authors: goldenberg sl. Prog Clin Biol Res. 1987;239:347-87. Prog Clin Biol Res. 1987. PMID: 3309961 Review. No abstract available.

9

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.

Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD. Gleave ME, et al. Among authors: goldenberg sl. J Urol. 1996 Jan;155(1):213-9. J Urol. 1996. PMID: 7490838 Clinical Trial.

10

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.

Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD, Akakura K. Goldenberg SL, et al. Urology. 1995 May;45(5):839-44; discussion 844-5. doi: 10.1016/s0090-4295(99)80092-2. Urology. 1995. PMID: 7538246 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters